We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.49B Turnover 10.26%
1-Year Est. Return 208.7%
This Fund
S&P 500
This Quarter Est. Return
-4.24%
1 Year Est. Return
+208.7%
3 Year Est. Return
+777.5%
5 Year Est. Return
+1,114.43%
10 Year Est. Return
+23,630.52%
AUM
$4.4B
AUM Growth
-$1.33B
Cap. Flow
-$405M
Cap. Flow %
-9.2%
Top 10 Hldgs %
53.32%
Holding
82
New
7
Increased
5
Reduced
49
Closed
11
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
+$220M
2
AUGX icon
Augmedix, Inc. Common Stock
AUGX
+$52.1M
3
TRDA icon
Entrada Therapeutics
TRDA
+$47.4M
4
CNC icon
Centene
CNC
+$26.5M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$24.6M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$100M
2
ARGX icon
argenx
ARGX
+$63.6M
3
DCPH icon
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$63.3M
4
SKIN icon
SkinHealth Systems
SKIN
+$61.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$38.3M

Sector Composition

Rank Sector Weight
1 Healthcare 96.18%
2 Consumer Staples 2.79%
3 Industrials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PROF icon
76
Profound Medical
PROF
$231M
– –
-787,346
Closed -$11.5M –
SNTI icon
77
Senti Biosciences Holdings
SNTI
$8.14M
– –
-192,490
Closed -$19.1M –
SYRS icon
78
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-3,891
Closed -$174K –
KA icon
79
DELISTED
Kineta, Inc. Common Stock
KA
– –
-8,498
Closed -$614K –
ONEM
80
DELISTED
1Life Healthcare
ONEM
– –
-600,432
Closed -$12.2M –
TCDA
81
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-54,758
Closed -$254K –
ITMR
82
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
– –
-264,600
Closed -$8M –
1 2 3
4

Similar funds

FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return

Redmile Group's Q4 2021 Portfolio in Review

As of Q4 2021, Redmile Group held 82 positions worth $4.4B, down 23% from $5.73B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Redmile Group withdrew a net $405M in Q4 2021, closing 11 positions and reducing 49 holdings. Its most notable exit was Amedisys, an estimated $22.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 97% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Redmile Group opened a new position in Science 37 Holdings, Inc. Common Stock worth $247M.

  • Redmile Group's largest Q4 2021 buy was Science 37 Holdings, Inc. Common Stock: 990,412 shares worth $247M.
  • Redmile Group added most to Amicus Therapeutics in Q4 2021, an estimated $21.4M increase.
  • Redmile Group's biggest Q4 2021 reduction was Jazz Pharmaceuticals, cutting an estimated $100M.
  • Redmile Group fully exited Amedisys in Q4 2021, selling an estimated $22.4M.
  • Redmile Group's ten largest holdings make up 53% of its $4.4B portfolio in Q4 2021.
  • Redmile Group opened 7 new positions and closed 11 in Q4 2021.
  • Redmile Group's portfolio value fell 23% quarter-over-quarter to $4.4B.

Based on Redmile Group's 13F filing for Q4 2021, filed 14 Feb 2022.